Fig. 2.
Investigator-assessed progression-free survival in non-Asian, Asian (excluding Japanese), and Japanese patients (data cutoff date: October 23, 2015). FUL fulvestrant, PAL palbociclib, PBO placebo
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.